Arrhythmias refractory to the treatment of lignocaine can be treated by
First, the core concept here is the treatment of arrhythmias, specifically those not responding to lidocaine. Lidocaine is a class 1b antiarrhythmic, used for ventricular arrhythmias like VT or PVCs. If it's not working, what's the next step?
The options are missing, but common alternatives might include other antiarrhythmics. Let's recall: in cases where lidocaine fails, procainamide (class 1a) or amiodarone (class III) are often used. Amiodarone is a broad-spectrum drug effective in many arrhythmias, including refractory cases. Procainamide is another option, but it has more side effects. So the correct answer is likely amiodarone.
Now, the incorrect options might include drugs like verapamil (class IV, used for SVT), propranolol (beta-blocker, not first-line for ventricular arrhythmias), or even digoxin (used in SVT with WPW but not for ventricular). Also, maybe mexiletine, which is another class 1b, but if lidocaine isn't working, mexiletine might not help either.
The clinical pearl here is that amiodarone is the drug of choice for refractory ventricular arrhythmias. It's important to remember its side effects, like pulmonary toxicity, but in acute situations, it's preferred.
So, putting it all together, the correct answer should be amiodarone. Let me structure the explanation accordingly, making sure to address each section as per the user's instructions.
**Core Concept**
Lidocaine, a class 1b antiarrhythmic, is used for ventricular arrhythmias by blocking sodium channels. Refractory cases require agents with broader mechanisms, such as amiodarone, which modulates multiple ion channels (Na⁺, K⁺, Ca²⁺) and has antiadrenergic effects.
**Why the Correct Answer is Right**
Amiodarone (class III antiarrhythmic) is the treatment of choice for arrhythmias unresponsive to lidocaine. It prolongs the action potential duration by inhibiting potassium efflux via the rapid component of the delayed rectifier current (Iₖr) and also reduces sodium and calcium influx. This multi-targeted approach makes it effective for both ventricular and supraventricular arrhythmias, including ventricular fibrillation and atrial fibrillation.
**Why Each Wrong Option is Incorrect**
**Option A:** Procainamide (class 1a) may worsen refractory arrhythmias due to its proarrhythmic potential and prolonged action potential.
**Option B:** Verapamil (class IV) is ineffective for ventricular arrhythmias and may exacerbate heart failure.
**Option C:** Propranolol (beta-blocker) is contraindicated in hypotensive or bradycardic patients and less effective for refractory ventricular arrhythmias.
**Option